US5147661046 - Common Stock
LIFECORE BIOMEDICAL INC
NASDAQ:LFCR (4/19/2024, 3:30:02 PM)
After market: 6.69 0 (0%)6.69
+0.38 (+5.94%)
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota. The firm and its subsidiaries design, develop, manufacture, and sell differentiated products for food and biomaterials markets, and license technology applications to partners. The firm specializes in specialty formulation, aseptic filling, and final packaging of both complex medical devices and injectable pharmaceuticals. The company manufactures commercial products at its three cGMP facilities. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form as well as formulated and filled syringes and vials for injectable products used in treating a broad spectrum of medical conditions and procedures. The company sells products utilizing hyaluronan that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets.
LIFECORE BIOMEDICAL INC
3515 Lyman Boulevard
Chaska MINNESOTA
P: 19523684300
Employees: 689
Website: https://www.lifecore.com/
CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the...
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ: LFCR). Such...
Here you can normally see the latest stock twits on LFCR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: